Eastgate Biotech Market Capitalization vs. Total Debt
| ETBIDelisted Stock | USD 0 0.00 0.00% |
For Eastgate Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Eastgate Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Eastgate Biotech Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Eastgate Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Eastgate Biotech Corp over time as well as its relative position and ranking within its peers.
Eastgate |
Eastgate Biotech Corp Total Debt vs. Market Capitalization Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Eastgate Biotech's current stock value. Our valuation model uses many indicators to compare Eastgate Biotech value to that of its competitors to determine the firm's financial worth. Eastgate Biotech Corp is one of the top stocks in market capitalization category among its peers. It also is rated as one of the top companies in total debt category among its peers making up about 8.10 of Total Debt per Market Capitalization. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eastgate Biotech's earnings, one of the primary drivers of an investment's value.Eastgate Market Capitalization vs. Competition
Eastgate Biotech Corp is one of the top stocks in market capitalization category among its peers. Market capitalization of Pharmaceuticals industry is currently estimated at about 109.1 Billion. Eastgate Biotech adds roughly 205,754 in market capitalization claiming only tiny portion of equities listed under Pharmaceuticals industry.
Eastgate Total Debt vs. Market Capitalization
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Eastgate Biotech |
| = | 205.75 K |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Eastgate Biotech |
| = | 1.67 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Eastgate Total Debt vs Competition
Eastgate Biotech Corp is rated as one of the top companies in total debt category among its peers. Total debt of Pharmaceuticals industry is currently estimated at about 101.75 Billion. Eastgate Biotech adds roughly 1.67 Million in total debt claiming only tiny portion of equities listed under Pharmaceuticals industry.
Eastgate Biotech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Eastgate Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Eastgate Biotech will eventually generate negative long term returns. The profitability progress is the general direction of Eastgate Biotech's change in net profit over the period of time. It can combine multiple indicators of Eastgate Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada. EASTGATE BIOTECH is traded on OTC Exchange in the United States.
Eastgate Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Eastgate Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Eastgate Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Eastgate Biotech's important profitability drivers and their relationship over time.
Use Eastgate Biotech in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eastgate Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eastgate Biotech will appreciate offsetting losses from the drop in the long position's value.Eastgate Biotech Pair Trading
Eastgate Biotech Corp Pair Trading Analysis
The ability to find closely correlated positions to Eastgate Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eastgate Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eastgate Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eastgate Biotech Corp to buy it.
The correlation of Eastgate Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eastgate Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eastgate Biotech Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eastgate Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Eastgate Biotech position
In addition to having Eastgate Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recreation Thematic Idea Now
Recreation
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Recreation theme has 34 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Eastgate Stock
If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |